Similar articles

• [Current status of clinical results of new antitumor drugs].

  Ogawa M. Ogawa M. Gan To Kagaku Ryoho. 1985 Feb;12(2):179-88. Gan To Kagaku Ryoho. 1985. PMID: 3918502 Review. Japanese.
• New cytotoxic drugs for breast cancer and their clinical evaluation.

  Carter SK. Carter SK. Eur J Cancer (1965). 1980;Suppl 1:265-70. Eur J Cancer (1965). 1980. PMID: 6459235 Review. No abstract available.
• New drugs and new delivery techniques.

  Feun LG, Lee YY, Wallace S, Charnsangavej C, Savaraj N, Carrasco CH, Gianturco C, Yung WK. Feun LG, et al. Prog Exp Tumor Res. 1985;29:131-9. doi: 10.1159/000411633. Prog Exp Tumor Res. 1985. PMID: 2416007 Review. No abstract available.
• Chemotherapy of ovarian cancer.

  Ozols RF, Young RC. Ozols RF, et al. Semin Oncol. 1984 Sep;11(3):251-63. Semin Oncol. 1984. PMID: 6435250 Review. No abstract available.
• [Chemotherapy for recurrent or advanced persistent epithelial ovarian cancer].

  Edelman DZ, Anteby SO, Peretz T. Edelman DZ, et al. Harefuah. 1996 Jul;131(1-2):31-6. Harefuah. 1996. PMID: 8854476 Review. Hebrew. No abstract available.